Found 41 matching trials
Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
PHASE4Evaluate the proportion of patients with an urticaria control test \[UCT\] ...
Location
Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
PHASE3This study will assess the efficacy, safety and tolerability of omalizumab,...
Location
Novartis Investigative Site
Shotblocker® Use in Subcutaneous Injection
NAAim: The aim of this study was to investigate the effect of subcutaneous in...
Location
University of Health Sciences
Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair
PHASE1A single dose, double blind comparative trial to assess the pharmacokinetic...
Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair®
PHASE1An open-label, randomized, in parallel groups comparative study of pharmaco...
Location
State budgetary institution of health care of the city of Moscow "City outpatients clinic No. 2 of the Department of Health of the city of Moscow"
Efficacy Study of Omalizumab in Cholinergic Urticaria
PHASE2To demonstrate the efficacy and safety of Omalizumab in a new indication, t...
Location
Departamento de Alergología. Clínica Universidad de Navarra
A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases
PHASE1This study aims to evaluate the safety, tolerability, pharmacokinetics (PK)...
Location
Hallym University Sacred Heart Hospital
Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria
PHASE2Chronic urticaria can be defined as the occurrence of widespread daily or a...
Location
Hospital Santiago Apostol
A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China
N/AThis non-interventional, multi-center, prospective post-approval study aims...
Location
Novartis Investigative Site
Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria
NAThis is a single center, non-comparative exploratory study, to investigate ...
Location
ASTHMA Inc Clinical Research Center